Judge Dismisses Genentech’s Lawsuit Accusing Amgen of Withholding Biosimilar Info

A U.S. district judge has dismissed a lawsuit alleging Amgen withheld manufacturing information from Genentech on an Avastin biosimilar.
Source: Drug Industry Daily